NKF Spring Clinical Meetings 2024
NKF Spring Clinical Meetings 2024
Advertisement
Cesia Portillo, MPHNKF Spring Clinical Meetings 2024 | June 4, 2024
Cesia Portillo discussed her poster on creating a roadmap for APOL1-mediated kidney disease (AMKD).
View More
Suzanne Watnick, MDNKF Spring Clinical Meetings 2024 | June 3, 2024
Suzanne Watnick shared thoughts on the Shaul G. Massry lectureship, COVID-19, kidney transplantation, and policy issues.
Yasemin Balin, MDNKF Spring Clinical Meetings 2024 | June 3, 2024
A. Ersin Yassa and Yasemin Balin were the winners of the inaugural Neph Madness tournament.
Joel M. Topf, MD, FACPNKF Spring Clinical Meetings 2024 | May 31, 2024
Martin Pollak reflected on winning the David M. Hume Memorial Award and on breakthroughs in glomerular diseases.
Sylvia Rosas, MD, MSCENKF Spring Clinical Meetings 2024 | May 31, 2024
Sylvia Rosas shared highlights from her term as president of the National Kidney Foundation.
Bhupinder Singh, MDNKF Spring Clinical Meetings 2024 | May 31, 2024
Bhupinder Singh and Stewart Turner discussed serum bicarbonate concentrations in patients with CKD and metabolic acidosis.
Michael SpiglerNKF Spring Clinical Meetings 2024 | May 30, 2024
Michael Spigler of American Kidney Fund discussed its work and its findings on education level and transplant discussions.
Areef Ishani, MDNKF Spring Clinical Meetings 2024 | May 30, 2024
Areef Ishani spoke about his abstract on renal outcomes with chlorthalidone versus hydrochlorothiazide for hypertension.
Chee Kay Cheung, PhD, MBChB, MRCPNKF Spring Clinical Meetings 2024 | May 29, 2024
Dr. Chee Kay Cheung discussed two presentations on IgA nephropathy findings from the SPARTAN and PROTECT studies.
Joel M. Topf, MD, FACPNKF Spring Clinical Meetings 2024 | May 24, 2024
Editorial board member Joel Topf reflects on the NKF Spring Clinical Meetings and the value of #NephTwitter.
Robert Montgomery, MD, PhDNKF Spring Clinical Meetings 2024 | May 29, 2024
Dr. Robert Montgomery spoke about advances in xenotransplantation, including the pig kidney transplant he recently performed.
Dana V. Rizk, MDNKF Spring Clinical Meetings 2024 | May 29, 2024
Dr. Dana Rizk discussed her APPLAUSE-IgAN study findings on iptacopan versus placebo for IgA nephropathy.
Mohamed G. Atta, MD, MPHNKF Spring Clinical Meetings 2024 | May 29, 2024
Dr. Mohamed G. Atta discussed the importance of educating clinicians about Fabry disease.
Ajay K. Singh, MBBS, FRCP, MBANKF Spring Clinical Meetings 2024 | May 29, 2024
Ajay K. Singh discussed his findings on daprodustat dosing and utilization of finerenone.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 24, 2024
Changes to the ordering plan could help optimize the use of SZC to treat acute hyperkalemia.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 18, 2024
Nocturnal hypertension is common in CKD, but it was unclear if renal denervation could lower nighttime blood pressure.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 17, 2024
A patient may have normal creatinine and complements but still have highly active lupus nephritis requiring therapy.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 24, 2024
Severe hyperkalemia after adrenalectomy is rare but can be managed medically with sodium zirconium cyclosilicate (SZC).
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 17, 2024
Sparsentan demonstrated meaningful benefits for preservation of kidney function compared with irbesartan over 2 years.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 23, 2024
Dose adjustment requirements may differ between ESA-hyporesponsive and non–ESA-HR patients receiving daprodustat.
Advertisement
Advertisement
Advertisement
Latest News

July 16, 2024